Skip to main content

Advertisement

Log in

Familial cancer of unknown primary

  • Letter to the Editor
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Cancer of unknown primary site (CUP) is a deadly disease diagnosed through metastases at various organs without primary tumor identification. Despite the major molecular and technological advances, the carcinogenesis of CUP remains enigmatic which hampers adequate study design of treatments leading to survival improvement. To date, the pathogenesis of CUP is still debatable with one hypothesis considering CUP simply a group of metastatic tumors with unidentified primaries and another considering it a distinct entity with specific genetic and phenotypic aberrations. Familial CUP seems to favor the first hypothesis due to common genetic predisposition factors between known primaries and CUP. Two clinical implications may be withdrawn from the pathogenesis of familial clustering of CUP. The detailed family history and environmental risk factors may orient towards the primary tumor identification. Smoking avoidance and adherence to general population guidelines for cancer screening would be strongly encouraged.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Pavlidis N, Khaled H, Gaafar R (2015) A mini review on cancer of unknown primary site: a clinical puzzle for the oncologists. J Adv Res 6:375–382. https://doi.org/10.1016/j.jare.2014.11.007

    Article  PubMed  Google Scholar 

  2. Pavlidis N, Pentheroudakis G (2012) Cancer of unknown primary site. Lancet Lond Engl 379:1428–1435. https://doi.org/10.1016/S0140-6736(11)61178-1

    Article  Google Scholar 

  3. Urban D, Rao A, Bressel M et al (2013) Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities. Br J Cancer 109:1318–1324. https://doi.org/10.1038/bjc.2013.386

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Fizazi K, Greco FA, Pavlidis N et al (2015) Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol 26(Suppl 5):v133–v138. https://doi.org/10.1093/annonc/mdv305

    Article  Google Scholar 

  5. Pentheroudakis G, Briasoulis E, Pavlidis N (2007) Cancer of unknown primary site: missing primary or missing biology? Oncologist 12:418–425. https://doi.org/10.1634/theoncologist.12-4-418

    Article  CAS  PubMed  Google Scholar 

  6. El Rassy E, Khaled H, Pavlidis N (2018) Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary. Eur J Cancer 105:28–32. https://doi.org/10.1016/j.ejca.2018.09.035

    Article  CAS  PubMed  Google Scholar 

  7. Hainsworth JD, Rubin MS, Spigel DR et al (2013) Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon Research Institute. J Clin Oncol 31:217–223. https://doi.org/10.1200/JCO.2012.43.3755

    Article  CAS  PubMed  Google Scholar 

  8. Moran S, Martínez-Cardús A, Sayols S et al (2016) Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. Lancet Oncol 17:1386–1395. https://doi.org/10.1016/S1470-2045(16)30297-2

    Article  PubMed  Google Scholar 

  9. El Rassy E, Pavlidis N (2018) The current evidence for a biomarker-based approach in cancer of unknown primary. Cancer Treat Rev 67:21–28. https://doi.org/10.1016/j.ctrv.2018.04.011

    Article  PubMed  Google Scholar 

  10. Pavlidis N (2007) Forty years experience of treating cancer of unknown primary. Acta Oncol 46:592–601. https://doi.org/10.1080/02841860701243095

    Article  PubMed  Google Scholar 

  11. Economopoulou P, Mountzios G, Pavlidis N et al (2015) Cancer of unknown primary origin in the genomic era: elucidating the dark box of cancer. Cancer Treat Rev 41:598–604. https://doi.org/10.1016/j.ctrv.2015.05.010

    Article  CAS  PubMed  Google Scholar 

  12. Hemminki K, Ji J, Sundquist J et al (2011) Familial risks in cancer of unknown primary: tracking the primary sites. J Clin Oncol 29:435–440. https://doi.org/10.1200/JCO.2010.31.5614

    Article  PubMed  Google Scholar 

  13. Samadder NJ, Smith KR, Hanson H et al (2016) Familial risk in patients with carcinoma of unknown primary. JAMA Oncol 2:340–346. https://doi.org/10.1001/jamaoncol.2015.4265

    Article  PubMed  Google Scholar 

  14. Vikeså J, Møller AKH, Kaczkowski B et al (2015) Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin. BMC Cancer 15:151. https://doi.org/10.1186/s12885-015-1128-x

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hemminki K, Chen B, Kumar A et al (2016) Germline genetics of cancer of unknown primary (CUP) and its specific subtypes. Oncotarget 7:22140–22149. https://doi.org/10.18632/oncotarget.7903

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lynch HT, Slostad B, Silberstein P (2016) Familial carcinoma of unknown primary. JAMA Oncol 2:346–347. https://doi.org/10.1001/jamaoncol.2015.4653

    Article  PubMed  Google Scholar 

  17. Linnebacher M, Gebert J, Rudy W et al (2001) Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens. Int J Cancer 93:6–11

    Article  CAS  PubMed  Google Scholar 

  18. Hemminki K, Sundquist K, Sundquist J et al (2016) Location of metastases in cancer of unknown primary are not random and signal familial clustering. Sci Rep. https://doi.org/10.1038/srep22891

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hemminki K, Bevier M, Sundquist J et al (2012) Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries? Ann Oncol 23:2720–2724. https://doi.org/10.1093/annonc/mds063

    Article  CAS  PubMed  Google Scholar 

  20. Oskarsson T, Batlle E, Massagué J (2014) Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell 14:306–321. https://doi.org/10.1016/j.stem.2014.02.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Kaaks R, Sookthai D, Hemminki K et al (2014) Risk factors for cancers of unknown primary site: results from the prospective EPIC cohort. Int J Cancer 135:2475–2481. https://doi.org/10.1002/ijc.28874

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicholas Pavlidis.

Ethics declarations

Conflict of interest

No author has any conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rassy, E., Kattan, J. & Pavlidis, N. Familial cancer of unknown primary. Int J Clin Oncol 24, 1328–1331 (2019). https://doi.org/10.1007/s10147-019-01491-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-019-01491-1

Keywords

Navigation